We encourage you to utilize these resources. If you have any further questions or require any additional information about Prolia, please contact Amgen Medical Information at 1-866-502-6436, or visit Amgen Medical
Information.
2010 Clinical Practice Guidelines
For the diagnosis and management of osteoporosis in Canada
ProVital® Enrolment Form
Download the ProVital® Patient Support Program enrolment form
FREEDOM Trial
Denosumab for Prevention of Fractures in Postmenopausal Women with Osteoporosis
Prolia® Product Monograph
Access a downloadable version of the Prolia® Product Monograph
Frequently Asked Questions
Answers to questions your patients may have about Prolia
References
1. | Amgen Canada Inc. Prolia® (denosumab injection) Product Monograph. November 24, 2023. |
2. | Cummings SR, et al. Denosumab for prevention of fractures in postmenopausal women with osteoporosis. N Engl J Med. 2009;361(8):756-765. |